Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021
July 6, 2022 | evokekyne
Evoke KYNE took home the Communiqué Communications Consultancy of the Year award at the 2021 Communiqué Awards held on 1 September at the Grosvenor House hotel in London.
David Kyne, CEO, Evoke KYNE said: “To be named the 2021 Communiqué Communications Consultancy of the Year following a year like no other, is particularly special. Across the industry we know 2020 was a year in which effective communications in healthcare played an increasingly important role. We are honoured to be formally recognised by the Communiqué judges and welcome their feedback on Evoke KYNE’s culture of inclusivity. I am grateful to work with such a talented, hard-working and dedicated team.”
Also in the running in this hotly contested category were Burson, Cohn & Wolfe (BCW), Hanover Health, Incisive Health and Lucid Group.
This year, the annual Communiqué Awards were once again held in person at the Grosvenor House hotel in London, with COVID-19 safety measures ensuring the well-being of all guests.
Commenting on the success of the night, Debbie Tuesley, Communiqué Awards Director said: “It was great to return for the first in-person Communiqué Awards since the outbreak of the pandemic in 2020. The level of work submitted this year was exceptionally high, reflecting the outstanding dedication of all those working across medical affairs and healthcare communications. Well done again to all the winners, highly commended and finalists for continuing to shine during an unprecedented period!”
See the full list of winners here.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Smarter science, sharper strategy: Expert insights from ASCO® 2026
As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?
Intelligent Commercialization™ across the pharma lifecycle
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.
Four steps to a smarter congress strategy: A practical guidebook
This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.
Infographic: Are data blind spots putting your launch at risk?
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…
Key takeaways from ASCO® 2026
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…
Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the…